Terug
Dagbereik
€ 23,28
€ 24,40
52-Weeksbereik
€ 12,72
€ 29,25
Volume
1.345.567
50D / 200D Gem.
€ 26,10
/
€ 20,79
Vorige Slotkoers
€ 24,38
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -11,7 | 0,4 |
| P/B | 6,9 | 2,9 |
| ROE % | -62,5 | 3,7 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 35,67
+49.6%
Low: € 16,00
High: € 50,00
Forward WPA
-€ 2,63
Omzet Sch.
10 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 2,09
€ 2,09 – € 2,09
|
1,3 B | 11 |
| FY2029 |
-€ 1,37
-€ 1,37 – -€ 1,37
|
460 M | 8 |
| FY2028 |
-€ 2,46
-€ 3,81 – -€ 1,47
|
110 M | 13 |
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -376,63M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-62,46%
ROIC-46,44%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,00
Current Ratio11,16
Interest Coverage0,00
Waardering
P/E Ratio
-11,72
P/B Ratio6,86
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -413,84M |
| ROE | -62,46% | ROA | -53,31% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -376,63M |
| ROIC | -46,44% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 11,16 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -11,72 | P/B Ratio | 6,86 |
| P/S Ratio | N/A | PEG Ratio | -0,14 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 4,85B | Enterprise Value | 4,14B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -413,84M | -259,34M | -210,96M | -156,73M | -107,43M |
| EPS (Diluted) | -2,73 | -1,88 | -1,71 | -1,43 | -1,22 |
| Gross Profit | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -438,15M | -270,21M | -208,28M | -156,03M | -108,12M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 776,22M | 666,71M | 405,84M | 515,56M | 412,49M |
| Total Liabilities | 68,78M | 48,96M | 43,34M | 45,74M | 21,01M |
| Shareholders' Equity | 707,45M | 617,76M | 362,49M | 469,83M | 391,48M |
| Total Debt | 98.000,0 | 138.000,0 | 1,22M | 2,36M | 3,42M |
| Cash & Equivalents | 713,97M | 635,37M | 376,53M | 493,82M | 400,15M |
| Current Assets | 767,66M | 665,77M | 404,33M | 512,93M | 409,01M |
| Current Liabilities | 68,78M | 48,61M | 43,30M | 44,52M | 18,77M |